Клоробен 30 мл спрей для слизистой оболочки полости рта

Country: Kyrgyzstan

Bahasa: Rusia

Sumber: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Bahan aktif:

Хлоргексидин глюконат+бензидамина гидрохлорид

Boleh didapati daripada:

Gurсan Eczа Deрosu Ve Ilac Tic Ltd Sti (Gurсan Eczа Deрosu Ve Ilac Tic Ltd Sti)

Kod ATC:

A01AD02

INN (Nama Antarabangsa):

Chlorhexidine gluconate+of benzydamine hydrochloride

Dos:

30 мл

Borang farmaseutikal:

спрей для слизистой оболочки полости рта

Unit dalam pakej:

№1

Jenis preskripsi:

без рецепта

Dikeluarkan oleh:

Drogsan Ilaclari San. Ve Tic.A.S (Турция)

Ringkasan produk:

ПЖВЛС: нет

Tarikh kebenaran:

2017-11-20

Ciri produk

YTBEPTTNAIO
llepnsrfi
3
aMecrr.rreJrb
Ar{peKTopa
JreKapcTBeHH0f0
nHcrcoft
TexHnKI{
paHeHr,l
2017
r.
I{HC
TpyKrILIfl
IIO
MEAI,TqI{HCKOMy
BEHHOTO
CPEACTBA
KJIOPOEEH@
Topronoe
Ha3BaHrre
Knopo6eH@
MexgyHapoAHoe
HerrareHToBaHHoe
Ha3BaHr{e
Her
Cocras
1
$naxon
(30vu)
coAepxr{r:
Arcmueuute
selqecmnq:xJlopreKceAr,rHa
rJrroKonar
0,036r,
6euszgaurlHa
rr{Apoxnopr4A
0,045r.
BcnouoeameflbHbte
6eu4ecm6q:
norzcop6ar
20
-
0,45r,
cop6urot
70o/o
-
3,00r,
rpolLrJreH
rJrI4KoJIb
-
3,00r, IIareHr
B
cunrzfi
-
0,00003r,
xr{HoJrzH
xenrrrfi
-
0,00006
r,
occeHrlrlr
Msrbr
nepeuHofi
-
0,0108r,
sKoKyn
-
0,03r,
cyKpano3a
-
0,105r,
MoHorr4Apar
nrzuonnofi
Kr.rcJrorbr
-
0,0165r,
Harpus
rlr{rpar
rtrrr4rpar
0,0525r,
rtrcrr4nnvpoBaHHair
BoAa
ro
30
un.
JlexapcrueHHaq
Sopnra
Cupefi
Ans
cJrr.r3r4crofi
o6onoqKu
rroJrocrr,r
pra.
Ouucanue
flpo:paunrrfi
pacrnop,
3eJleHofo
uBera,
Kr4cno-ropbKoro
BKyca
rr
c
ocBexarcqr.rM
M{THbrM
3AIIAXOM.
@apvrarcorepaneBTuqecrcaq
rpyrrrra
flpourae
npelaparbr
,4rf
[eqeHr4s
ga6oresaHraft
nolocru
pra.
Kol
ATX:
A01AD
OaplrarconorrrrrecKoe
cnoft
crso
(DapmaxoduHun
uKa
BeH:u4auuu
-
Hecrepol4AHoe
rlporl4BoBocnaJrr4TeJrbHoe
u
o6eg6oruBaroqee
BeurecrBo,
orJrvqarcrueect
or
Apyfl4x
HIIBC.
Byayvu
ocHoBaHI4eM,
B
KoHIIeHTparryrflx
ucnonb3yeMbrx
rrpt4
JroKzurbHoM
rrpvMeHeHprlr,
oKa3blBaer
uecrnrrfi
aHecre3apyroulzfi
eQQerr.
Ha
sncnepzMeHTzurbHbrx
MoAeJr.flx,
o6es6olzoarorqee
4eficraze
6euszgantuua
6olee
BbIptDKeHo
npu
6olrx,
Bbr3BaHHbrx
BocrraJreHr.reM,
Helr(eJrlr
npu
6onx
HeBocrrail,ITeJlbHoro
xapaKTepa.
XroprercugvHa
rJrroKoHar
rBJrrerw
6uc6uryaH[AoM
c
runporofi
rlporl{BoMlzKpo6Hofi
aKrl{BHocrbro.
flocre
MecrHoro
rprdMeHeHn.rr,
xJroprcKculvHa
rJrroKoHar
a4cop6zpyercs.
Ha
rloBepxHocrIa
sy6on,
crugucrofi pra
v
HilneroB,
MeAJreHno
ocso6ox{Aaercs
B
cnloHy
B
TerreHrr{
24,lp'cos.
QapmaxoxuHemuKa
BeH:u4arraun
xopouo
a6cop6upyercr
qepe3
BocrraneHHyro
cnr43r4cryro
a
nposBnser
nporLIBoBocIIaJILITenbHoe
u
MecrHoe
aHecre3Lrpyrcqee
4eficrnue.
flpu
uecrHoM
nprzMeHeHkrvr,
npulrtuztttenbHo
30% xnopreKcrrrqrna yAepxr4Baercr
B
porosofi
uorocrz.
B
reqeHr4r